Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The study is to evaluate the efficacy and safety of lenalidomide in the treatment of oral
ulcers in adult patients with refractory mucosal Behcet's syndrome.